Sarge, I disagree, if the company is looking to maximise impact and profits, then Australia should be the last region it seeks approvals for.
@Joelsmith2452 .... we are in the middle of a once in a one hundred year pandemic; multiple submissions should be lodged simultaneously in multiple regions IMO ... no one knows where or when an outbreak will occur ... one of the main reasons I wanted a large pharma deal to handle things like multiple regulatory submissions - we simply don’t have the resources
Viraleze marketing, page-89
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
